The FDA on Monday granted full approval to Pfizer and BioNTech Covid-19 vaccine, becoming the first Covid vaccine in the U.S., according to a report by CNBC on Monday.
- Until now, the mRNA vaccine was on the U.S. market under an Emergency Use Authorization that was given by the FDA in December.
- US Federal health officials have been under growing pressure from the scientific community and advocacy groups to fully approve Pfizer and BioNTech’s vaccine.
- The companies had submitted a Biologics License Application, which secures full approval. FDA scientists evaluated hundreds of thousands of pages of vaccine data.
- Pfizer’s vaccine met the agency’s high standards for safety, effectiveness and manufacturing quality.
Many Americans are still hesitant about getting vaccinated, even as the highly contagious delta spreads. Full approval may convince Americans that the shots are safe. Full approval is “more psychological than anything else. PFE up +3.31%, MRNA up +5.11%